177 related articles for article (PubMed ID: 11214093)
1. In-vivo sensitivity of Plasmodium vivax isolates from Rond nia (western Amazon region, Brazil) to regimens including chloroquine and primaquine.
Villalobos-Salcedo JM; Tada MS; Kimura E; Menezes MJ; Pereira da Silva LH
Ann Trop Med Parasitol; 2000 Dec; 94(8):749-58. PubMed ID: 11214093
[TBL] [Abstract][Full Text] [Related]
2. Monitoring the Efficacy of Chloroquine-Primaquine Therapy for Uncomplicated Plasmodium vivax Malaria in the Main Transmission Hot Spot of Brazil.
Ladeia-Andrade S; Menezes MJ; de Sousa TN; Silvino ACR; de Carvalho JF; Salla LC; Nery OA; de Melo GNP; Corder RM; Rodrigues PT; Ferreira MU
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782991
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Plasmodium vivax malaria recurrence in Brazil.
Daher A; Silva JCAL; Stevens A; Marchesini P; Fontes CJ; Ter Kuile FO; Lalloo DG
Malar J; 2019 Jan; 18(1):18. PubMed ID: 30670020
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia.
Yeshiwondim AK; Tekle AH; Dengela DO; Yohannes AM; Teklehaimanot A
Acta Trop; 2010 Feb; 113(2):105-13. PubMed ID: 19835832
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India.
Rishikesh K; Kamath A; Hande MH; Vidyasagar S; Acharya RV; Acharya V; Belle J; Shastry AB; Saravu K
Malar J; 2015 Aug; 14():310. PubMed ID: 26259839
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia.
Alvarez G; Piñeros JG; Tobón A; Ríos A; Maestre A; Blair S; Carmona-Fonseca J
Am J Trop Med Hyg; 2006 Oct; 75(4):605-9. PubMed ID: 17038680
[TBL] [Abstract][Full Text] [Related]
7. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.
Llanos-Cuentas A; Lacerda MV; Rueangweerayut R; Krudsood S; Gupta SK; Kochar SK; Arthur P; Chuenchom N; Möhrle JJ; Duparc S; Ugwuegbulam C; Kleim JP; Carter N; Green JA; Kellam L
Lancet; 2014 Mar; 383(9922):1049-58. PubMed ID: 24360369
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
Walsh DS; Wilairatana P; Tang DB; Heppner DG; Brewer TG; Krudsood S; Silachamroon U; Phumratanaprapin W; Siriyanonda D; Looareesuwan S
Clin Infect Dis; 2004 Oct; 39(8):1095-103. PubMed ID: 15486831
[TBL] [Abstract][Full Text] [Related]
9. Primaquine for preventing relapses in people with Plasmodium vivax malaria.
Galappaththy GN; Omari AA; Tharyan P
Cochrane Database Syst Rev; 2007 Jan; (1):CD004389. PubMed ID: 17253504
[TBL] [Abstract][Full Text] [Related]
10. Chloroquine-Primaquine versus Chloroquine Alone to Treat Vivax Malaria in Afghanistan: An Open Randomized Superiority Trial.
Awab GR; Imwong M; Bancone G; Jeeyapant A; Day NPJ; White NJ; Woodrow CJ
Am J Trop Med Hyg; 2017 Dec; 97(6):1782-1787. PubMed ID: 29141719
[TBL] [Abstract][Full Text] [Related]
11. Treatment of vivax malaria on the western border of Thailand.
Luxemburger C; van Vugt M; Jonathan S; McGready R; Looareesuwan S; White NJ; Nosten F
Trans R Soc Trop Med Hyg; 1999; 93(4):433-8. PubMed ID: 10674098
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the efficacy of 8 weeks of primaquine for the prevention of relapse in vivax malaria patients using SSCP-PCR and sequencing in South and South-East Iran, 2008-2011.
Miahipour A; Keshavarz H; Heidari A; Raeisi A; Rezaeian M; Rezaei S
Trans R Soc Trop Med Hyg; 2013 Jul; 107(7):420-6. PubMed ID: 23694816
[TBL] [Abstract][Full Text] [Related]
13. Short report: primaquine-tolerant Plasmodium vivax in an Italian traveler from Guatemala.
Signorini L; Matteelli A; Castelnuovo F; Castelli F; Oladeji O; Carosi G
Am J Trop Med Hyg; 1996 Nov; 55(5):472-3. PubMed ID: 8940974
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Chloroquine and Primaquine for the Treatment of Uncomplicated Plasmodium vivax Malaria in Cruzeiro do Sul, Brazil.
Negreiros S; Farias S; Viana GM; Okoth SA; Chenet SM; de Souza TM; Marchesini P; Udhayakumar V; Povoa MM; Santelli AC; de Oliveira AM
Am J Trop Med Hyg; 2016 Nov; 95(5):1061-1068. PubMed ID: 27549633
[TBL] [Abstract][Full Text] [Related]
15. Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India.
Yadav RS; Ghosh SK
J Parasitol; 2002 Oct; 88(5):1042-4. PubMed ID: 12435158
[TBL] [Abstract][Full Text] [Related]
16. In vivo sensitivity monitoring of chloroquine for the treatment of uncomplicated vivax malaria in four bordered provinces of Thailand during 2009-2010.
Congpuon K; Satimai W; Sujariyakul A; Intanakom S; Harnpitakpong W; Pranuth Y; Cholpol S; Bualombai P
J Vector Borne Dis; 2011 Dec; 48(4):190-6. PubMed ID: 22297279
[TBL] [Abstract][Full Text] [Related]
17. Quantifying and preventing Plasmodium vivax recurrences in primaquine-untreated pregnant women: An observational and modeling study in Brazil.
Corder RM; de Lima ACP; Khoury DS; Docken SS; Davenport MP; Ferreira MU
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008526. PubMed ID: 32735631
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of chloroquine followed by primaquine for Plasmodium vivax treatment in Azerbaijan.
Valibayov A; Abdullayev F; Mammadov S; Gasimov E; Sabatinelli G; Kondrachine AV; Ringwald P
Acta Trop; 2003 Sep; 88(1):99-102. PubMed ID: 12943984
[TBL] [Abstract][Full Text] [Related]
19. Studies on Plasmodium vivax relapse pattern in Kheda district, Gujarat.
Srivastava HC; Sharma SK; Bhatt RM; Sharma VP
Indian J Malariol; 1996 Dec; 33(4):173-9. PubMed ID: 9125831
[TBL] [Abstract][Full Text] [Related]
20. Higher-Dose Primaquine to Prevent Relapse of
Chamma-Siqueira NN; Negreiros SC; Ballard SB; Farias S; Silva SP; Chenet SM; Santos EJM; Pereira de Sena LW; Póvoa da Costa F; Cardoso-Mello AGN; Marchesini PB; Peterka CRL; Viana GMR; Macedo de Oliveira A
N Engl J Med; 2022 Mar; 386(13):1244-1253. PubMed ID: 35353962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
